|
|
Blood, 15 October 2008, Vol. 112, No. 8, pp. 3339-3347.
Prepublished online as a Blood First Edition Paper on August 6, 2008; DOI 10.1182/blood-2008-01-134783.
Previous Article | Next Article 
Submitted January 18, 2008
Accepted July 21, 2008
Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3
Bjorn Lamprecht, Stephan Kreher, Ioannis Anagnostopoulos, Korinna Johrens, Giovanni Monteleone, Franziska Jundt, Harald Stein, Martin Janz, Bernd Dorken, and Stephan Mathas*
Max-Delbruck-Center for Molecular Medicine, Berlin, Germany
Hematology, Oncology and Tumorimmunology, Charite, Medical University Berlin, Berlin, Germany
Institute for Pathology, Charite, Medical University Berlin, Berlin, Germany
Departimento di Medicina Interna, Universita Tor Vergata, Rome, Italy
* Corresponding author; email: stephan.mathas{at}charite.de.
The malignant Hodgkin-/Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (HL) are derived from mature B cells, but have lost a considerable part of the B cell-specific gene expression pattern. Consequences of such a lineage infidelity for lymphoma pathogenesis are currently not defined. Here, we report that HRS cells aberrantly express the common cytokine-receptor -chain ( c) cytokine IL-21, which is usually restricted to a subset of CD4+ T cells, and the corresponding IL-21 receptor. We demonstrate that IL-21 activates STAT3 in HRS cells, up-regulates STAT3 target genes, and protects HRS cells from CD95 death receptor-induced apoptosis. Furthermore, IL-21 is involved in up-regulation of the CC chemokine macrophage-inflammatory protein-3 (MIP-3 ) in HRS cells. MIP-3 in turn attracts CCR6+CD4+CD25+FoxP3+CD127lo regulatory T cells towards HRS cells, which might favour their immune escape. Together, these data support the concept that aberrant expression of B lineage-inappropriate genes plays an important role for the biology of HL tumor cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Dien Bard, P. Gelebart, M. Anand, Z. Zak, S. A. Hegazy, H. M. Amin, and R. Lai
IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma
Am. J. Pathol.,
August 1, 2009;
175(2):
825 - 834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Konforte, N. Simard, and C. J. Paige
IL-21: An Executor of B Cell Fate
J. Immunol.,
February 15, 2009;
182(4):
1781 - 1787.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|